e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Assessment and management of immune-mediated interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A comparison of existing questionnaires for identifying the causes of interstitial and rare lung diseases
M. Polke (Germany), D. Kirsten (Schleswig-Holstein, Germany), B. Teucher (Heidelberg, Germany), U. Costabel (Essen, Germany), F. Herth (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany)
Source:
International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Session:
Assessment and management of immune-mediated interstitial lung diseases
Session type:
Thematic Poster
Number:
4728
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Polke (Germany), D. Kirsten (Schleswig-Holstein, Germany), B. Teucher (Heidelberg, Germany), U. Costabel (Essen, Germany), F. Herth (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany). A comparison of existing questionnaires for identifying the causes of interstitial and rare lung diseases. 4728
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Clinical spectrum of children with interstitial pneumonia with autoimmune features:a new definition in childhood interstitial lung diseases
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021
The internet-based network for the management of children with interstitial lung disease
Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease
Year: 2014
Comparison of registries of interstitial lung diseases in three European countries
Source: Eur Respir J 2001; 18: 114S-118S
Year: 2001
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018
Year: 2018
Clinical management of the idiopathic interstitial pneumonias: an example of an integrated approach to interstitial lung diseases
Source: Annual Congress 2006 - PG8 - Interstitial lung diseases: idiopathic interstitial pneumonias
Year: 2006
The effectiveness of pulmonary rehabilitation in interstitial lung diseases in terms of functional markers
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018
Prevalence and characteristics of cystic lung lesions in children with interstitial lung diseases – a register-based study
Source: Virtual Congress 2021 – Paediatric bronchology
Year: 2021
The best ERJ papers in interstitial and rare lung diseases
Source: International Congress 2018 – The best of the European Respiratory Journal in 2018
Year: 2018
Current challenges in diagnosing and treating adults with interstitial lung disease
Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease
Year: 2014
Two new NKX2-1 mutations associated with pediatric interstitial lung diseases
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Identifying pulmonary hypertension in newly recognized interstitial lung diseases – a role of new scoring system
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
Clusters, classification and epidemiology of interstitial lung diseases: concepts, methods and critical reflections
Source: Eur Respir J 2001; 18: 101S-106S
Year: 2001
Medication for childhood interstitial lung diseases differs internationally
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
The management of children with interstitial lung disease
Source: International Congress 2018 – Difficult paediatric lung disease
Year: 2018
The genetics of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190053; 10.1183/16000617.0053-2019
Year: 2019
A new diagnostic approach for interstitial lung diseases: Cryobiopsy
Source: International Congress 2017 – To freeze or heat?
Year: 2017
Immundefects, rare pulmonary infections and rare lung diseases
Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases
Year: 2020
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019
Year: 2019
A case of occupational interstitial disease: when to invade the lungs and when non-invasive diagnostic investigations may be useful
Source: International Congress 2019 – Occupational and epidemiology Grand Round
Year: 2019
Longitudinal cost of care in individuals with different subtypes of interstitial lung diseases
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept